HomeInsights52 Week Low Stocks

Bliss Gvs Pharma Ltd 52 Week Low

Bliss Gvs Pharma Ltd 52 Week Low

stocks purchased

₹ 0.6 Cr

Volume Transacted

(Dec 26, 2024)

stocks purchased

38.4 K

Stocks Traded

(Dec 26, 2024)

Last Updated on: Dec 26, 2024

Image

Bliss GVS Pharma Ltd

NSE: BLISSGVS

YEARLOW

₹ 92.25

Last updated on: Dec 26, 2024

Key Highlights

  • The 52 Week Low of Bliss GVS Pharma Ltd is ₹ 92.25 as of 26 Dec 24 .

Company Fundamentals for Bliss GVS Pharma Ltd

No data available

Market Price of Bliss GVS Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Bliss GVS Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
26 Dec 2024162.15
24 Dec 2024159.9
23 Dec 2024158.85
20 Dec 2024161.35
19 Dec 2024170.1
18 Dec 2024167.35
17 Dec 2024167.9
16 Dec 2024175.7
13 Dec 2024175.85
12 Dec 2024173.8

Asset Value vs Market Value of Bliss GVS Pharma Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Bliss GVS Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Bliss GVS Pharma Ltd

No data available

* All values are in crore

Bliss GVS Pharma Ltd News Hub

News

Bliss GVS Pharma allots 34,250 equity shares under ESOP

Bliss GVS Pharma has allotted 34,250 equity shares under ESOP on 06 December 2024. With th...

Read more

06 Dec 2024 19:02

News

Bliss GVS Pharma soars after manufacturing units get GMP certificate from Romania medical authority

In a regulatory filing made on Saturday, the company informed that its manufacturing facil...

Read more

25 Nov 2024 09:40

News

Bliss GVS Pharma's manufacturing facilities complete EU GMP inspection

Bliss GVS Pharma announced that the company's manufacturing facility situated at Plot No. ...

Read more

23 Nov 2024 15:02

News

Bliss GVS Pharma to table results

Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 24 Octobe...

Read more

18 Oct 2024 10:48

News

Bliss GVS Pharma allots 1.57 lakh equity shares under ESOP

Bliss GVS Pharma has allotted 157,550 equity shares under ESOP on 04 October 2024. With th...

Read more

04 Oct 2024 18:37

News

Bliss GVS Pharma to convene board meeting

Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 24 July 2...

Read more

18 Jul 2024 11:35

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week Low of Bliss GVS Pharma Ltd

Why is it important to track the 52-week low of Bliss GVS Pharma Ltd stocks?

Investors should monitor the 52-week low of Bliss GVS Pharma Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Bliss GVS Pharma Ltd stocks hitting a 52-week low?

Factors leading to Bliss GVS Pharma Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Bliss GVS Pharma Ltd stocks when they hit a 52-week low?

Buying Bliss GVS Pharma Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Bliss GVS Pharma Ltd stocks?

Investors should monitor the 52-week low of Bliss GVS Pharma Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Bliss GVS Pharma Ltd stock at their 52-week low?

An investor can analyze the reasons for the Bliss GVS Pharma Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Bliss GVS Pharma Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Bliss GVS Pharma Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Bliss GVS Pharma Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions